Stock NXTCL NEXTCELL PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

News NextCell Pharma AB

Equities

NXTCL

SE0009723125

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:31 2024-05-31 EDT 		5-day change 1st Jan Change
1.515 SEK -23.10% Intraday chart for NextCell Pharma AB +4.12% -42.40%
05-27 Nextcell Pharma AB Elects Hans-Peter Ekre as New Chairman of the Board CI
04-25 NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
The subscription period in NextCell's rights issue commences today
AQ
NextCell publishes prospectus in connection with the rights issue of units of approximately SEK 40.1 million
AQ
Single treatment with ProTrans demonstrates long-term therapeutic effect over 5 years
AQ
Bulletin from the Extraordinary General Meeting of NextCell Pharma AB (publ)
AQ
Nextcell Pharma AB Elects Hans-Peter Ekre as New Chairman of the Board
CI
NextCell publishes its Interim Report 2 2023/2024
AQ
NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024
CI
Notice of Extraordinary General Meeting in NextCell Pharma AB (publ)
AQ
The Board of Directors of NextCell resolves on a rights issue of units of approximately SEK 40.1 million, subject to approval by an Extraordinary General Meeting
AQ
NextCell's daughter company Cellaviva granted permission to handle amniotic tissue
AQ
NextCell Pharma AB Announces Swedish Health and Social Care Inspectorate Grants Their Cellaviva Tissue Establishment Permission to Handle Amniotic Tissue
CI
NextCell Pharma Chairman to Step Down in May
MT
Anders Essen-Möller resigns as Chairman of the Board of Directors due to health reasons
AQ
Anders Essen-Möller Resigns as Chairman of NextCell Pharma AB
CI
The Swedish Medical Products Agency approves subgroup analysis in NextCell's ProTrans-Young study
AQ
The Swedish Medical Products Agency Approves Subgroup Analysis in NextCell Pharma AB's ProTrans-Young study
CI
NextCell establishes QVance to meet the Nordic's need for quality analytics
AQ
NextCell Pharma AB Establishes QVance to Meet the Nordic's Need for Quality Analytics
CI
NextCell Pharma's updated growth strategy
AQ
NextCell Pharma presents at Redeye Theme: Regenerative Medicine/Cell Therapy
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NXTCL Stock
  4. News NextCell Pharma AB